导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.90% | 805/1050 |
| 近一周 | -2.38% | 578/1104 |
| 近一月 | -2.43% | 263/1102 |
| 近一季 | 1.15% | 197/1092 |
| 近半年 | -8.27% | 711/1070 |
| 近一年 | -8.67% | 721/1018 |
| 近两年 | 15.87% | 807/926 |
| 近三年 | -0.93% | 687/834 |
| 成立以来 | -22.23% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.74% 796/1070 |
-9.45% 896/1101 |
- - |
- - |
| 2025 | 13.36% 781/1065 |
4.01% 479/1014 |
2.57% 463/1038 |
10.27% 849/1050 |
-3.64% 642/1065 |
| 2024 | 1.60% 535/1011 |
0.46% 290/960 |
2.42% 175/983 |
4.69% 891/991 |
-5.67% 707/1011 |
| 2023 | -16.73% 590/952 |
5.19% 312/880 |
2.90% 70/895 |
-19.48% 857/915 |
-4.45% 447/952 |
| 2022 | -16.88% 218/867 |
-13.72% 208/773 |
-5.14% 761/806 |
-15.10% 576/845 |
19.63% 19/867 |
| 2021 | -10.55% 487/740 |
-7.68% 441/580 |
25.13% 88/659 |
-8.44% 463/704 |
-15.43% 683/740 |
| 2020 | - - |
- - |
- - |
- - |
12.03% 293/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 长盛竞争优势A VS. 东吴新产业精选股票A(580008) |